Urinalysis parameters as a useful tool to predict severity in coronavirus disease 2019 (COVID19)

M. Mjid (TUNIS, Tunisia), W. JELASSI (TUNIS, Tunisia), Y. Yahia (TUNIS, Tunisia), Y. Messaoudi (TUNIS, Tunisia), S. Khiari (TUNIS, Tunisia), A. Allouche (TUNIS, Tunisia), M. Klila (TUNIS, Tunisia), Y. Ouahchi (TUNIS, Tunisia), M. Gharbi (TUNIS, Tunisia), S. Cheikhrouhou (TUNIS, Tunisia), H. Maghraoui (TUNIS, Tunisia), F. Daly (TUNIS, Tunisia), S. Merai (TUNIS, Tunisia), S. Toujani (TUNIS, Tunisia), B. Dhahri (TUNIS, Tunisia)

Source: Virtual Congress 2021 – COVID - 19
Session: COVID - 19
Session type: E-poster
Number: 3490

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mjid (TUNIS, Tunisia), W. JELASSI (TUNIS, Tunisia), Y. Yahia (TUNIS, Tunisia), Y. Messaoudi (TUNIS, Tunisia), S. Khiari (TUNIS, Tunisia), A. Allouche (TUNIS, Tunisia), M. Klila (TUNIS, Tunisia), Y. Ouahchi (TUNIS, Tunisia), M. Gharbi (TUNIS, Tunisia), S. Cheikhrouhou (TUNIS, Tunisia), H. Maghraoui (TUNIS, Tunisia), F. Daly (TUNIS, Tunisia), S. Merai (TUNIS, Tunisia), S. Toujani (TUNIS, Tunisia), B. Dhahri (TUNIS, Tunisia). Urinalysis parameters as a useful tool to predict severity in coronavirus disease 2019 (COVID19). 3490

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease
Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018
Year: 2018



Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017

COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015


Multiple breath washout technique is a helpful clinical tool for assessing respiratory disease - pro
Source: International Congress 2018 – Current and evolving tests in lung function: pro/con debate
Year: 2018


Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006

I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Pulmonary function testing: an useful oracle for predicting the pattern of bacterial pathogens in sputum of patients with acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003

Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018



CT patterns of lung damage and prognosis markers for the course of a new coronavirus infection COVID-19 in persons with comorbidity
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021


What is the best biomarker of COVID-19 pneumonia progression?
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Is early serological investigation an useful diagnostic tool in pneumonia by M. pneumoniae?
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005

Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 443s
Year: 2002

Accurate and reliable determination of alpha1-antitrypsin levels in respiratory patients using dried blood spot specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Gene polymorphism could be a useful prognostic tool in patients with work-related chronic bronchitis
Source: Annual Congress 2012 - COPD beyond tobacco
Year: 2012


Comparison of the two scoring indices (curb65 and psi) and detemination of their utility in predicting the severity of community acquired pneumonia among patients seen at philippine heart center
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009